$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 35 36 37 38 39 40 41 42 43 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.78 | 40,000 | 191,252 | 85,000 | 45 K to 85 K (+88.89 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 57.35 | 30,000 | 1,720,500 | 30,000 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | A | 57.35 | 26,250 | 1,505,438 | 26,250 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 57.35 | 26,250 | 1,505,438 | 26,250 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | MADIGAN JOHN W | Director | Option Exercise | A | 57.35 | 26,250 | 1,505,438 | 26,250 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 57.35 | 32,500 | 1,863,875 | 32,500 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 6,500 | 31,078 | 75,000 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | A | 57.35 | 30,000 | 1,720,500 | 30,000 | |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 57.23 | 1,200 | 68,676 | 9,000 | 10.2 K to 9 K (-11.76 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 57.35 | 860 | 49,321 | 10,200 | 11.1 K to 10.2 K (-7.78 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 57.27 | 2,040 | 116,831 | 11,060 | 13.1 K to 11.1 K (-15.57 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 57.24 | 2,400 | 137,376 | 13,100 | 15.5 K to 13.1 K (-15.48 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | DAVIGNON ETIENNE | Director | Grant | A | 0.00 | 7,250 | 0 | 219,250 | 212 K to 219.3 K (+3.42 %) |
| May 11 2006 | GILD | GILEAD SCIENCES IN ... | CARACCIOLO ANTHONY | SVP, Manufacturing | Option Exercise | A | 56.52 | 40,000 | 2,260,800 | 40,000 | |
| May 01 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 3.27 | 10,000 | 32,657 | 40,000 | |
| May 01 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 3.27 | 10,000 | 32,657 | 17,679 | 7.7 K to 17.7 K (+130.23 %) |
| May 05 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 3.27 | 20,000 | 65,314 | 20,000 | |
| May 05 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 3.27 | 20,000 | 65,314 | 37,679 | 17.7 K to 37.7 K (+113.13 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 6,500 | 31,078 | 81,500 | |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.29 | 1,100 | 65,219 | 9,000 | 10.1 K to 9 K (-10.89 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.28 | 1,200 | 71,136 | 10,100 | 11.3 K to 10.1 K (-10.62 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.25 | 1,400 | 82,950 | 11,300 | 12.7 K to 11.3 K (-11.02 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.24 | 600 | 35,544 | 12,700 | 13.3 K to 12.7 K (-4.51 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.23 | 100 | 5,923 | 13,300 | 13.4 K to 13.3 K (-0.75 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 59.16 | 900 | 53,244 | 13,400 | 14.3 K to 13.4 K (-6.29 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 58.82 | 1,200 | 70,584 | 14,300 | 15.5 K to 14.3 K (-7.74 %) |
| Mar 10 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 1,900 | 25,845 | 3,576 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 9.81 | 5,000 | 49,050 | 1,000 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 7.41 | 2,994 | 22,174 | 0 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 7.40 | 5,000 | 36,993 | 0 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.06 | 1,900 | 24,819 | 34,248 | 32.3 K to 34.2 K (+5.87 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 9.81 | 5,000 | 49,050 | 32,348 | 27.3 K to 32.3 K (+18.28 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 7.40 | 5,000 | 36,993 | 27,348 | 22.3 K to 27.3 K (+22.37 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 7.41 | 2,994 | 22,174 | 22,348 | 19.4 K to 22.3 K (+15.47 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.78 | 400 | 1,913 | 71,600 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 3.13 | 39,600 | 123,750 | 0 | |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 60.02 | 2,036 | 122,201 | 45,000 | 47 K to 45 K (-4.33 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 60.01 | 771 | 46,268 | 47,036 | 47.8 K to 47 K (-1.61 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 60.00 | 975 | 58,500 | 47,807 | 48.8 K to 47.8 K (-2.00 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.99 | 50 | 3,000 | 48,782 | 48.8 K to 48.8 K (-0.10 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.94 | 1,068 | 64,016 | 48,832 | 49.9 K to 48.8 K (-2.14 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.80 | 5,000 | 299,000 | 49,900 | 54.9 K to 49.9 K (-9.11 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.77 | 500 | 29,885 | 54,900 | 55.4 K to 54.9 K (-0.90 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.76 | 444 | 26,533 | 55,400 | 55.8 K to 55.4 K (-0.80 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.75 | 9,156 | 547,071 | 55,844 | 65 K to 55.8 K (-14.09 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.65 | 100 | 5,965 | 65,000 | 65.1 K to 65 K (-0.15 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.64 | 344 | 20,516 | 65,100 | 65.4 K to 65.1 K (-0.53 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.63 | 700 | 41,741 | 65,444 | 66.1 K to 65.4 K (-1.06 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.61 | 100 | 5,961 | 66,144 | 66.2 K to 66.1 K (-0.15 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.60 | 2,200 | 131,120 | 66,244 | 68.4 K to 66.2 K (-3.21 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.57 | 900 | 53,613 | 68,444 | 69.3 K to 68.4 K (-1.30 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.56 | 400 | 23,824 | 69,344 | 69.7 K to 69.3 K (-0.57 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 59.50 | 5,256 | 312,732 | 69,744 | 75 K to 69.7 K (-7.01 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 4.78 | 400 | 1,913 | 75,000 | 74.6 K to 75 K (+0.54 %) |
| Mar 08 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 3.13 | 39,600 | 123,750 | 74,600 | 35 K to 74.6 K (+113.14 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.10 | 9,891 | 604,340 | 205,661 | 215.6 K to 205.7 K (-4.59 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.11 | 1,800 | 109,998 | 215,552 | 217.4 K to 215.6 K (-0.83 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.13 | 1,500 | 91,695 | 217,352 | 218.9 K to 217.4 K (-0.69 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.14 | 3,999 | 244,499 | 218,852 | 222.9 K to 218.9 K (-1.79 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.19 | 100 | 6,119 | 222,851 | 223 K to 222.9 K (-0.04 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.18 | 200 | 12,236 | 222,951 | 223.2 K to 223 K (-0.09 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.20 | 200 | 12,240 | 223,151 | 223.4 K to 223.2 K (-0.09 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.21 | 500 | 30,605 | 223,351 | 223.9 K to 223.4 K (-0.22 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.22 | 310 | 18,978 | 223,851 | 224.2 K to 223.9 K (-0.14 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.23 | 200 | 12,246 | 224,161 | 224.4 K to 224.2 K (-0.09 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.24 | 100 | 6,124 | 224,361 | 224.5 K to 224.4 K (-0.04 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.25 | 600 | 36,750 | 224,461 | 225.1 K to 224.5 K (-0.27 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.27 | 100 | 6,127 | 225,061 | 225.2 K to 225.1 K (-0.04 %) |
| Feb 24 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Sell | S | 61.28 | 500 | 30,640 | 225,161 | 225.7 K to 225.2 K (-0.22 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 3.27 | 120,000 | 391,884 | 210,360 | |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.72 | 5,000 | 308,600 | 728,217 | 733.2 K to 728.2 K (-0.68 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.73 | 5,000 | 308,650 | 733,217 | 738.2 K to 733.2 K (-0.68 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.76 | 7,000 | 432,320 | 738,217 | 745.2 K to 738.2 K (-0.94 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.74 | 10,000 | 617,400 | 745,217 | 755.2 K to 745.2 K (-1.32 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.79 | 20,000 | 1,235,800 | 755,217 | 775.2 K to 755.2 K (-2.58 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.70 | 34,000 | 2,097,800 | 775,217 | 809.2 K to 775.2 K (-4.20 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 61.69 | 39,000 | 2,405,910 | 809,217 | 848.2 K to 809.2 K (-4.60 %) |
| Feb 17 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 3.27 | 120,000 | 391,884 | 848,217 | 728.2 K to 848.2 K (+16.48 %) |
| Feb 16 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 61.00 | 100 | 6,100 | 262 | 362 to 262 (-27.62 %) |
| Feb 16 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 60.75 | 19,900 | 1,208,925 | 362 | 20.3 K to 362 (-98.21 %) |
| Feb 16 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 60.25 | 30,000 | 1,807,500 | 20,262 | 50.3 K to 20.3 K (-59.69 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 16.44 | 40,000 | 657,500 | 353,920 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.40 | 96,488 | 713,866 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Option Exercise | M | 7.40 | 13,512 | 99,969 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.34 | 5,000 | 296,700 | 518,581 | 523.6 K to 518.6 K (-0.95 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.23 | 1,000 | 59,230 | 523,581 | 524.6 K to 523.6 K (-0.19 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.22 | 10,000 | 592,200 | 524,581 | 534.6 K to 524.6 K (-1.87 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.10 | 49,000 | 2,895,900 | 534,581 | 583.6 K to 534.6 K (-8.40 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.05 | 25,000 | 1,476,250 | 583,581 | 608.6 K to 583.6 K (-4.11 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.04 | 11,488 | 678,252 | 608,581 | 620.1 K to 608.6 K (-1.85 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.03 | 10,000 | 590,300 | 620,069 | 630.1 K to 620.1 K (-1.59 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Sell | S | 59.02 | 25,000 | 1,475,500 | 630,069 | 655.1 K to 630.1 K (-3.82 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 16.44 | 40,000 | 657,500 | 655,069 | 615.1 K to 655.1 K (+6.50 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.40 | 96,488 | 713,866 | 615,069 | 518.6 K to 615.1 K (+18.61 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, Research | Buy | M | 7.40 | 13,512 | 99,969 | 518,581 | 505.1 K to 518.6 K (+2.68 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 16.44 | 862 | 14,169 | 6,586 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 11.76 | 1,888 | 22,199 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 9.81 | 1,000 | 9,810 | 1,000 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 9.34 | 3,000 | 28,031 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 7.41 | 4,800 | 35,550 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 7.40 | 3,208 | 23,734 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 7.30 | 11,624 | 84,819 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 7.08 | 2,000 | 14,156 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 4.47 | 58,664 | 262,158 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Option Exercise | M | 2.86 | 12,000 | 34,313 | 0 | |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 16.44 | 862 | 14,169 | 225,661 | 224.8 K to 225.7 K (+0.38 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 9.81 | 1,000 | 9,810 | 224,799 | 223.8 K to 224.8 K (+0.45 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 7.40 | 3,208 | 23,734 | 223,799 | 220.6 K to 223.8 K (+1.45 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 11.76 | 1,888 | 22,199 | 220,591 | 218.7 K to 220.6 K (+0.86 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 7.30 | 11,624 | 84,819 | 218,703 | 207.1 K to 218.7 K (+5.61 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 9.34 | 3,000 | 28,031 | 207,079 | 204.1 K to 207.1 K (+1.47 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 7.41 | 4,800 | 35,550 | 204,079 | 199.3 K to 204.1 K (+2.41 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 7.08 | 2,000 | 14,156 | 199,279 | 197.3 K to 199.3 K (+1.01 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 4.47 | 58,664 | 262,158 | 197,279 | 138.6 K to 197.3 K (+42.32 %) |
| Feb 15 2006 | GILD | GILEAD SCIENCES IN ... | YANG TAIYIN | SVP, Pharm Dev & Mf ... | Buy | M | 2.86 | 12,000 | 34,313 | 138,615 | 126.6 K to 138.6 K (+9.48 %) |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 11.76 | 21,472 | 252,466 | 0 | |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 9.34 | 14,000 | 130,813 | 0 | |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 59.50 | 600 | 35,697 | 13,551 | 14.2 K to 13.6 K (-4.24 %) |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 59.34 | 34,872 | 2,069,304 | 14,151 | 49 K to 14.2 K (-71.13 %) |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 11.76 | 21,472 | 252,466 | 49,023 | 27.6 K to 49 K (+77.94 %) |
| Feb 13 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 9.34 | 14,000 | 130,813 | 27,551 | 13.6 K to 27.6 K (+103.31 %) |
| Feb 09 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Option Exercise | M | 7.30 | 10,000 | 72,969 | 83,896 | |
| Feb 09 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 60.50 | 10,000 | 605,000 | 50,262 | 60.3 K to 50.3 K (-16.59 %) |
| Feb 09 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 60.20 | 30,000 | 1,806,000 | 60,262 | 90.3 K to 60.3 K (-33.24 %) |
| Feb 09 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 60.22 | 10,000 | 602,200 | 7,679 | 17.7 K to 7.7 K (-56.56 %) |
| Feb 09 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.30 | 10,000 | 72,969 | 17,689 | 7.7 K to 17.7 K (+130.06 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Option Exercise | M | 11.76 | 30,000 | 352,737 | 17,824 | |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.52 | 100 | 6,052 | 98,521 | 98.6 K to 98.5 K (-0.10 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.59 | 200 | 12,118 | 98,621 | 98.8 K to 98.6 K (-0.20 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.61 | 200 | 12,122 | 98,821 | 99 K to 98.8 K (-0.20 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.62 | 200 | 12,124 | 99,021 | 99.2 K to 99 K (-0.20 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.51 | 300 | 18,153 | 99,221 | 99.5 K to 99.2 K (-0.30 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.53 | 400 | 24,212 | 99,521 | 99.9 K to 99.5 K (-0.40 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.57 | 400 | 24,228 | 99,921 | 100.3 K to 99.9 K (-0.40 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.58 | 500 | 30,290 | 100,321 | 100.8 K to 100.3 K (-0.50 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.63 | 600 | 36,378 | 100,821 | 101.4 K to 100.8 K (-0.59 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.56 | 3,900 | 236,184 | 101,421 | 105.3 K to 101.4 K (-3.70 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.60 | 4,200 | 254,520 | 105,321 | 109.5 K to 105.3 K (-3.83 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Sell | S | 60.50 | 19,000 | 1,149,500 | 109,521 | 128.5 K to 109.5 K (-14.78 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | EVP, Chief Financia ... | Buy | M | 11.76 | 30,000 | 352,737 | 128,521 | 98.5 K to 128.5 K (+30.45 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 35.35 | 11,793 | 416,883 | 176,895 | |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | M | 32.02 | 13,207 | 422,888 | 108,670 | |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.16 | 10,500 | 642,180 | 1,254 | 11.8 K to 1.3 K (-89.33 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.19 | 200 | 12,238 | 11,754 | 12 K to 11.8 K (-1.67 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.20 | 400 | 24,480 | 11,954 | 12.4 K to 12 K (-3.24 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.18 | 1,800 | 110,124 | 12,354 | 14.2 K to 12.4 K (-12.72 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.21 | 3,200 | 195,872 | 14,154 | 17.4 K to 14.2 K (-18.44 %) |
| Feb 07 2006 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Sell | S | 61.22 | 100 | 6,122 | 17,354 | 17.5 K to 17.4 K (-0.57 %) |